Clinical trial
Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX
NCT00479583 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00479583 |
|---|---|
| Title | Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX |
| Official title | A Phase I Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of BMS-690514 in Combination With FOLFIRI and FOLFOX in Subjects With Advanced Metastatic Solid Tumors |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | BMS-690514 / FOLFIRI, BMS-690514 / FOLFOX |
| Enrollment | 25 |
| Start date | Sep 1, 2007 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | May 28, 2007 |
| Last update posted | Nov 30, 2011 |
| Countries | France, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: